INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
![Foto de INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)](/img/noimage.png)
![Foto de Karolinska University Hospital](/img/noimage_org.png)
Karolinska University Hospital
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska University Hospital (44)
2023
2022
-
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
European Respiratory Journal, Vol. 59, Núm. 2
-
Thrombectomy for secondary distal, medium vessel occlusions of the posterior circulation: seeking complete reperfusion
Journal of NeuroInterventional Surgery, Vol. 14, Núm. 7, pp. 654-659
2021
-
Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe
Methods in Molecular Biology (Humana Press Inc.), pp. 227-239
-
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Cell Death and Disease, Vol. 12, Núm. 6
-
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype
Cell Death and Disease, Vol. 12, Núm. 11
-
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation
American Journal of Respiratory and Critical Care Medicine, Vol. 203, Núm. 1, pp. 37-53
2020
-
Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects
Adipocyte, Vol. 9, Núm. 1, pp. 116-119
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
-
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications, Vol. 11, Núm. 1
-
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)
Nature Communications
2019
-
Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)
Nature Communications
-
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Nature Communications, Vol. 10, Núm. 1
-
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
European Respiratory Journal
-
Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion
OncoImmunology, Vol. 8, Núm. 11
2018
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology, Vol. 12, Núm. 1
-
Calcium signaling and cell cycle: Progression or death
Cell Calcium, Vol. 70, pp. 3-15
-
Immune effectors responsible for the elimination of hyperploid cancer cells
OncoImmunology, Vol. 7, Núm. 8
-
eIF2α phosphorylation is pathognomonic for immunogenic cell death
Cell Death and Differentiation, Vol. 25, Núm. 8, pp. 1375-1393
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691